Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pulmonary Disease: early-phase trial registry
8 of 20 indexed Pulmonary Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #848 of 28,707 conditions by registered trial count.
20 US clinical trials · 8 currently recruiting · #848 of 28,707 conditions by registered trial count
Pulmonary Disease: 20 US clinical trials tracked, 8 recruiting.
Pulmonary Disease is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Boston University, running 2 of these trials.
Enrollment posture brief
Registry condition pulmonary-disease
OPEN 8 | RECR 40% | LATE 0 | EARLY 2 | RANK #848 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Pulmonary Disease lists 8 open slots (40% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pulmonary Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pulmonary Disease recruits in line with its size-band peers.
8 of 20 indexed trials (40%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Pulmonary Disease trials is spread across many organizations.
Boston University accounts for 2 of 20 trials (10%). 17 distinct sponsors appear on at least one study for this condition label.
-
Typical Pulmonary Disease enrolment sits around 209 participants.
Median target enrolment is 209 among the 20 trials that report a genuine target (sentinel values excluded). 8 of those (40%) plan for fewer than 100 participants.
-
Pulmonary Disease splits between interventional and observational designs.
9 interventional and 11 observational studies make up this index (45% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
20 total, page 1 of 1
Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
The University of Texas Health Science Center at San Antonio
NCT05006729
Study of Lung Proteins in Patients With Pneumonia
National Institutes of Health Clinical Center (CC)
NCT00077909
Cooperative Assessment of Late Effects for SCD Curative Therapies
Vanderbilt University Medical Center
NCT05153967
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
University of Texas Southwestern Medical Center
NCT04164173
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
National Institutes of Health Clinical Center (CC)
NCT01730092
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
Oregon Health and Science University
NCT06775106
Quantitative Pulmonary Imaging Registry & Biorepository
University of Kansas Medical Center
NCT05530408
Merck IIT: RRP Pembro and Lenvatinib
Yale University
NCT04645602
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Boston University
NCT02504697
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Edwards Lifesciences
NCT03130777
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
Boston University
NCT04165564
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
Vanderbilt University Medical Center
NCT04996173
Exacerbations Among Patients Receiving Breztri (EROS Study)
AstraZeneca
NCT06514144
World Trade Center (WTC) CHEST
Icahn School of Medicine at Mount Sinai
NCT01466218
Evaluation and Treatment of Patients With Lung Disease Not Participating in Research
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001621
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
NCT03767517
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
NYU Langone Health
NCT02671669
High Flow vs Conventional Oxygen in Head and Neck Surgery
University of Florida
NCT05362526
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
Global Alliance for TB Drug Development
NCT05526911
Engineering Evaluation of the Helix Ventilator
Philips Respironics
NCT03613363
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Pulmonary Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pulmonary Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pulmonary Disease page
20 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Pulmonary Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boston University sponsors the most Pulmonary Disease trials on record, review their full trial history before evaluating a specific study. See Boston University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Disease condition card totals 20 registered trials; most-linked intervention Active Intervention; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.